Cardiovascular Revascularization Medicine
Volume 9, Issue 3 , Pages 132-139 , July 2008

Risk stratification after successful coronary revascularization

  • Masashi Goto

      Affiliations

    • Kyoto University Health Service, Yoshida-Honmachi, Sakyo-ku, Kyoto 606-8501, Japan
    • Corresponding Author InformationCorresponding author. Kyoto University Health Service, Yoshida-Honmachi, Sakyo-ku, Kyoto 606-8501, Japan. Tel.: +81 75 753 2400; fax: +81 75 753 2424.
    • ,
  • Shun Kohsaka

      Affiliations

    • Texas Heart Institute at St. Luke's Episcopal Hospital and Baylor College of Medicine, Houston, TX 77030, USA
    • ,
  • Noriaki Aoki

      Affiliations

    • University of Texas School of Health Information Sciences, Houston, TX 77030, USA
    • ,
  • Vei-Vei Lee

      Affiliations

    • Texas Heart Institute at St. Luke's Episcopal Hospital and Baylor College of Medicine, Houston, TX 77030, USA
    • ,
  • MacArthur A. Elayda

      Affiliations

    • Texas Heart Institute at St. Luke's Episcopal Hospital and Baylor College of Medicine, Houston, TX 77030, USA
    • ,
  • James M. Wilson

      Affiliations

    • Texas Heart Institute at St. Luke's Episcopal Hospital and Baylor College of Medicine, Houston, TX 77030, USA

Received 15 December 2007 ,Revised 16 March 2008 ,Accepted 26 March 2008.

References 

  1. Coronary artery surgery study (CASS): a randomized trial of coronary artery bypass surgery. Survival data. Circulation. 1983;68:939–950
  2. Alderman EL, Bourassa MG, Cohen LS, Davis KB, Kaiser GG, Killip T, et al. Ten-year follow-up of survival and myocardial infarction in the randomized Coronary Artery Surgery Study. Circulation. 1990;82:1629–1646
  3. Braunwald E. Effects of coronary-artery bypass grafting on survival: implications of the randomized coronary-artery surgery study. N Engl J Med. 1983;309:1181–1184
  4. SoS Investigators: Coronary artery bypass surgery versus percutaneous coronary intervention with stent implantation in patients with multivessel coronary artery disease (the Stent or Surgery trial): a randomised controlled trial. Lancet. 2002;360:965–970
  5. Legrand VM, Serruys PW, Unger F, van Hout BA, Vrolix MC, Fransen GM, et al. Three-year outcome after coronary stenting versus bypass surgery for the treatment of multivessel disease. Circulation. 2004;109:1114–1120
  6. Rodriguez A, Bernardi V, Navia J, Baldi J, Grinfeld L, Martinez J, et al. Argentine Randomized Study: Coronary Angioplasty with Stenting versus Coronary Bypass Surgery in patients with Multiple-Vessel Disease (ERACI II): 30-day and one-year follow-up results. ERACI II Investigators. J Am Coll Cardiol. 2001;37:51–58
  7. Rodriguez A, Rodríguez Alemparte M, Baldi J, Navia J, Delacasa A, Vogel D, et al. Coronary stenting versus coronary bypass surgery in patients with multiple vessel disease and significant proximal LAD stenosis: results from the ERACI II study. Heart. 2003;89:184–188
  8. Rodriguez AE, Baldi J, Fernández Pereira C, Navia J, Rodriguez Alemparte M, Delacasa A, et al. Five-year follow-up of the Argentine randomized trial of coronary angioplasty with stenting versus coronary bypass surgery in patients with multiple vessel disease (ERACI II). J Am Coll Cardiol. 2005;46:582–588
  9. Serruys PW, Unger F, Sousa JE, Jatene A, Bonnier HJ, Schönberger JP, et al. Comparison of coronary-artery bypass surgery and stenting for the treatment of multivessel disease. N Engl J Med. 2001;344:1117–1124
  10. Unger F, Serruys PW, Yacoub MH, Ilsley C, Paulsen PK, Nielsen TT, et al. Revascularization in multivessel disease: comparison between two-year outcomes of coronary bypass surgery and stenting. J Thorac Cardiovasc Surg. 2003;125:809–820
  11. Chen LY, Lennon RJ, Grantham JA, Berger PB, Mathew V, Singh M, et al. In-hospital and long-term outcomes of multivessel percutaneous coronary revascularization after acute myocardial infarction. Am J Cardiol. 2005;95:349–354
  12. Hannan EL, Racz MJ, Walford G, Jones RH, Ryan TJ, Bennett E, et al. Long-term outcomes of coronary-artery bypass grafting versus stent implantation. N Engl J Med. 2005;352:2174–2183
  13. van Domburg RT, Foley DP, de Feyter PJ, van der Giessen W, van den Brand MJ, Serruys PW. Long-term clinical outcome after coronary balloon angioplasty: identification of a population at low risk of recurrent events during 17 years of follow-up. Eur Heart J. 2001;22:934–941
  14. Villareal RP, Lee VV, Elayda MA, Wilson JM. Coronary artery bypass surgery versus coronary stenting: risk-adjusted survival rates in 5,619 patients. Tex Heart Inst J. 2002;29:3–9
  15. Breiman L, Friedman JH, Olshen RA, Stone CJ. Classification and Regression Trees. Belmont (Calif): Wadsworth International Group; 1984;
  16. Quinlan JR. Induction of decision trees. Mach Learn. 1986;1:81
  17. Coronary angioplasty versus medical therapy for angina: the second Randomised Intervention Treatment of Angina (RITA-2) trial. RITA-2 trial participants. Lancet. 1997;350:461–468
  18. Hartigan PM, Giacomini JC, Folland ED, Parisi AF. Two- to three-year follow-up of patients with single-vessel coronary artery disease randomized to PTCA or medical therapy (results of a VA cooperative study). Veterans Affairs Cooperative Studies Program ACME Investigators. Angioplasty Compared to Medicine. Am J Cardiol. 1998;82:1445–1450
  19. Henderson RA, Pocock SJ, Clayton TC, Knight R, Fox KA, Julian DG, et al. Second Randomized Intervention Treatment of Angina (RITA-2) Trial Participants. Seven-year outcome in the RITA-2 trial: coronary angioplasty versus medical therapy. J Am Coll Cardiol. 2003;42:1161–1170
  20. DeBakey ME, Glaeser DH. Patterns of atherosclerosis: effect of risk factors on recurrence and survival-analysis of 11,890 cases with more than 25-year follow-up. Am J Cardiol. 2000;85:1045–1053
  21. Kip KE, Faxon DP, Detre KM, Yeh W, Kelsey SF, Currier JW. Coronary angioplasty in diabetic patients. The National Heart, Lung, and Blood Institute Percutaneous Transluminal Coronary Angioplasty Registry. Circulation. 1996;94:1818–1825
  22. Stein B, Weintraub WS, Gebhart SP, Cohen-Bernstein CL, Grosswald R, Liberman HA, et al. Influence of diabetes mellitus on early and late outcome after percutaneous transluminal coronary angioplasty. Circulation. 1995;91:979–989
  23. Thourani VH, Weintraub WS, Stein B, Gebhart SS, Craver JM, Jones EL, et al. Influence of diabetes mellitus on early and late outcome after coronary artery bypass grafting. Ann Thorac Surg. 1999;67:1045–1052
  24. Brooks MM, Jones RH, Bach RG, Chaitman BR, Kern MJ, Orszulak TA, et al. Predictors of mortality and mortality from cardiac causes in the bypass angioplasty revascularization investigation (BARI) randomized trial and registry. For the BARI Investigators. Circulation. 2000;101:2682–2689
  25. Five-year clinical and functional outcome comparing bypass surgery and angioplasty in patients with multivessel coronary disease: a multicenter randomized trial. Writing Group for the Bypass Angioplasty Revascularization Investigation (BARI) Investigators. JAMA. 1997;277:715–721
  26. Brener SJ, Lytle BW, Casserly IP, Schneider JP, Topol EJ, Lauer MS. Propensity analysis of long-term survival after surgical or percutaneous revascularization in patients with multivessel coronary artery disease and high-risk features. Circulation. 2004;109:2290–2295
  27. King SB, Barnhart HX, Kosinski AS, Weintraub WS, Lembo NJ, Petersen JY, et al. Angioplasty or surgery for multivessel coronary artery disease: comparison of eligible registry and randomized patients in the EAST trial and influence of treatment selection on outcomes. Emory Angioplasty versus Surgery Trial Investigators. Am J Cardiol. 1997;79:1453–1459
  28. van Domburg RT, Takkenberg JJ, Noordzij LJ, Saia F, van Herwerden LA, Serruys PW, et al. Late outcome after stenting or coronary artery bypass surgery for the treatment of multivessel disease: a single-center matched-propensity controlled cohort study. Ann Thorac Surg. 2005;79:1563–1569
  29. Kohsaka S, Goto M, Lee VV, Virani S, Aoki N, Elayda MA, Reul RM, Wilson JM. Long-term clinical outcome of coronary artery stenting or CABG in patients with multiple vessel disease. J Thorac Cardiovasc Surg (in press).

☆ This work was presented at the 7th Scientific Forum on Quality of Care and Outcomes Research in Cardiovascular Disease and Stroke in Washington, DC, on May 8, 2006.

☆☆ This study was supported by the Banyu Fellowship Program sponsored by Banyu Life Science Foundation International (Tokyo, Japan). The authors have no potential conflicts of interest.

PII: S1553-8389(08)00121-8

doi: 10.1016/j.carrev.2008.03.005

Cardiovascular Revascularization Medicine
Volume 9, Issue 3 , Pages 132-139 , July 2008

Article Tools

* Image Usage & Resolution